Predictmedix AI Inc., a Canadian technology company listed on the Canadian National Stock Exchange, specializes in the development and implementation of artificial intelligence (AI) solutions. The company’s primary focus is on predictive analytics, utilizing advanced AI algorithms to forecast and optimize business processes. By leveraging machine learning and data analysis, Predictmedix AI Inc. aims to enhance decision-making capabilities, improve efficiency, and drive growth for its business clients.
As of January 8, 2026, the company’s share price closed at 0.055 CAD. Over the past year, the stock has experienced moderate volatility, with a 52-week high of 0.09 CAD on November 23, 2025, and a 52-week low of 0.01 CAD on February 3, 2025. The current share price is situated roughly at the midpoint of this range, indicating a period of relative stability in the stock’s performance.
The market capitalization of Predictmedix AI Inc. stands at 11,373,314 CAD. However, the company’s price-to-earnings ratio is reported at -5.8, reflecting the absence of positive earnings over the past year. This metric underscores the challenges faced by the company in achieving profitability, despite its strategic focus on AI and predictive analytics.
In terms of corporate communications, Predictmedix AI Inc. has not issued any new public updates as of January 12, 2026. The most recent disclosure, dated December 17, 2025, was a year-end update provided by thecse.com. The lack of recent announcements suggests a period of relative quiet in investor communications, which may be indicative of the company’s current strategic focus or operational adjustments.
Overall, Predictmedix AI Inc. continues to position itself as a leader in the field of predictive analytics, leveraging its expertise in AI to offer innovative solutions to businesses. Despite the challenges reflected in its financial metrics, the company remains committed to enhancing its offerings and driving growth through technological advancements.
